logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 11738064 B1

PDFFull Text
Date of Patent:
Aug. 29, 2023

Filed:

Mar. 17, 2021

Pharmaceutical composition for preventing and treating eye diseases, containing as active ingredient, fusion protein in which tissue-penetrating peptide and anti-vascular endothelial growth factor preparation are fused

Applicant:

Ildong Pharm Co., Ltd., Seoul, KR;

Inventors:

Seong Beom Kim, Gyeonggi-do, KR;

Hyei Yoon Jung, Seoul, KR;

Seok Woo Yang, Gyeonggi-do, KR;

Hyuk Sang Kwon, Seoul, KR;

Jae-Hoon Kang, Seoul, KR;

Yong-Sung Kim, Gyeonggi-do, KR;

Assignee:

ILDONG PHARM CO., LTD., Seoul, KR;

Attorney:

LEASON ELLIS LLP

Primary Examiner:

Christine J Saoud

Int. Cl.
CPC ...
A61K 39/395 (2006.01); A61K 38/17 (2006.01); A61K 38/16 (2006.01); A61K 47/64 (2017.01); A61K 39/00 (2006.01); A61P 27/02 (2006.01); A61P 43/00 (2006.01); A61K 38/18 (2006.01); C07K 14/475 (2006.01);
U.S. Cl.
CPC ...
A61K 38/179 (2013.01); A61K 38/16 (2013.01); A61K 38/1866 (2013.01); A61K 39/001135 (2018.08); A61K 39/395 (2013.01); A61K 47/64 (2017.08); A61P 27/02 (2018.01); A61P 43/00 (2018.01); C07K 14/475 (2013.01); C07K 2319/74 (2013.01);
Abstract

The present invention relates to a pharmaceutical composition comprising, as an active ingredient, a fusion protein in which a tissue-penetrating peptide is fused to an anti-vascular endothelial growth factor agent, methods of treating eye diseases with the pharmaceutical composition, and a method for preparing an anti-VEGF agent with an improved efficacy and ability to overcome resistance.

Find Patent Forward Citations

Kim, Seong. (2023). Pharmaceutical composition for preventing and treating eye diseases, containing as active ingredient, fusion protein in which tissue-penetrating peptide and anti-vascular endothelial growth factor preparation are fused (U.S. Patent No. 11738064). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/11738064

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…